Pradžia › Pjautinio ląstelės anemija › Virginia
Pjautinio ląstelės anemija klinikiniai tyrimai Virginia
9 tyrimai dėl Pjautinio ląstelės anemija ieško dalyvių vietose Virginia.
Miestai Virginia
Oficialus tyrimo tekstas (anglų kalba)
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Inova Health System, Fairfax
- Children's Hsptl Of The Kings, Norfolk
- Virginia Comm Univ Medical Ctr, Richmond
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06612268Early Screening and Treatment of Heart Complication in Sickle Cell Disease
- Inova Schar Cancer, Fairfax
- Inova Health Care Service, Falls Church
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07023666A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Inova Schar Cancer Institute, Fairfax
- Virginia Commonwealth University (VCU) Medical Center, Richmond
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT06481306A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Inova Schar Cancer Institute, Fairfax
Renkami dalyviai2/3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Hospital of Kings Daughters, Norfolk
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Virginia Commonwealth University, Richmond
Renkami dalyviai2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Virginia Commonwealth University, Richmond
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- VCU Massey Cancer Center: Dalton Oncology Clinic- Site Number : 8400012, Richmond
Renkami dalyviai3 fazė
Amžius nuo 10 iki 65 · Visoms lytims · Atnaujinta 2026-07-29 · NCT06975865Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Virginia Commonwealth University, Richmond
Renkami dalyviai
Amžius nuo 16 iki 30 · Visoms lytims · Atnaujinta 2026-01-07 · NCT06374238Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.